Страна: Израиль
Язык: английский
Источник: Ministry of Health
FERROUS AS IRON III HYDROXIDE POLYMALTOSE COMPL.; FOLIC ACID
CTS CHEMICAL INDUSTRIES LTD, ISRAEL
B03AD01
TABLETS
FOLIC ACID 0.4 MG; FERROUS AS IRON III HYDROXIDE POLYMALTOSE COMPL. 100 MG
PER OS
Not required
CTS CHEMICAL INDUSTRIES LTD, ISRAEL
FERROUS AMINO ACID COMPLEX
FERROUS AMINO ACID COMPLEX
Prevention and treatment of anemia caused by iron and folic acid deficiency including anemia of pregnancy and lactation.
2014-06-30
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS )PREPARATIONS( – 1986 This medicine is dispensed without a doctor's prescription FERRIFOL TABLETS Each tablet contains: Iron )as Iron III Hydroxide Polymaltose Complex( 100 mg and folic acid 0.4 mg. Inactive ingredients and allergens in the medicine - see section 6 “Additional information” and section 2 “Important information about some ingredients of the medicine”. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have any other questions, refer to the doctor or the pharmacist. Use the medicine according to the instructions in the dosage section of this leaflet. CONSULT THE PHARMACIST IF YOU HAVE FURTHER QUESTIONS. Refer to the doctor if signs of the ailment )symptoms( worsen or do not improve after three weeks. The medicine is usually intended for adults and children above 12 years of age. 1. WHAT IS THE MEDICINE INTENDED FOR? The medicine is intended for prevention and treatment of anemia due to iron and folic acid deficiency, including during pregnancy and breastfeeding. THERAPEUTIC CLASS: Iron in combination with folic acid. Iron is an essential constituent of red blood cells )hemoglobin(, of muscle cells )myoglobin( and of iron-containing enzymes. Folic acid is a vitamin that is important for fetal development. Folic acid deficiency in the early weeks of pregnancy may lead to fetal malformations. 2. BEFORE USING THE MEDICINE: DO NOT USE THIS MEDICINE IF: You are sensitive )allergic( to the active ingredients or to any of the additional components the medicine contains. You have an excess of iron in your body )e.g., deficiency caused by a rare disease of iron accumulation, which may lead to build-up of iron in the tissues(. You have a problem with efficient utilization of iron )e.g., when anemia is caused by inefficient utilization of iron(. You have anemia that is not caused by iron deficiency )e.g., anemia caused by increased hemoglobin breakdown or by Прочитать полный документ
FERRIFOL TABLETS , per os ACTIVE SUBSTANCES Ferrifol tablets contain 100 mg Iron as iron III hydroxide polymaltose complex and 0.4 mg folic acid. INDICATIONS Prevention and treatment of anaemia caused by iron and folic acid deficiency including anaemia of pregnancy and lactation. EXCIPIENTS Ferrifol tablets contain: Dextrates, Polyethylene Glycol 6000, Purified Talc, Aspartame, Magnesium Stearate, Chocolate Essence POSOLOGY/ADMINISTRATION Adults and children above 12 years of age: For prevention of anaemia: one tablet per day. For treatment of anaemia: 3 tablets per day taken as one daily dose or as separate doses. Ferrifol tablets should be taken with or directly after meals and can be chewed or swallowed whole. _Paediatric Population _ Ferrifol tablets are not indicated for children and adolescents below 12 years of age. CONTRAINDICATIONS - known hypersensitivity to or intolerance of the active substances or one of the excipients - iron overload (e.g. haemochromatosis, haemosiderosis) - iron metabolism disorders (lead anaemia, sideroachrestic anaemia, thalassaemia) - any anaemia not caused by iron deficiency (e.g. haemolytic anaemia or megaloblastic anaemia caused by vitamin B12 deficiency) SPECIAL WARNINGS AND PRECAUTIONS Anaemias should always be treated under the supervision of a doctor. If therapeutic success (increase in haemoglobin by about 2 – 3 g/dL after 3 weeks) is not achieved, treatment should be reconsidered. Ferrifol contains folic acid which can mask a vitamin B12 deficiency. A potential vitamin B12 deficiency must be ruled out before the start of treatment in anaemic patients due to the risk of irreversible neurological dysfunctions, see “Contraindications”. During treatment with Ferrifol there may be dark discolouration of the faeces (stool), however this is of no clinical relevance. Caution is recommended in patients who receive repeated blood transfusions, as there is a supply of iron with erythrocytes, which can lead to iron overload. Infections or tumours can cause anaemia. As oral ir Прочитать полный документ